The Phase 2 Examinations assess candidates on radiation oncology, and pathology, as well as their ability to analyse, interpret, and apply this knowledge and intrinsic role competencies to the assessment and management of patients with cancer. Held twice a year, these exams are usually taken in the final year of training.
To pass, candidates must succeed in all subject domains and components: Radiation Oncology and Pathology.
Practice on the provided digital platform is recommended and resources such as past exam papers and sample questions are available to help candidates prepare.
Refer to Radiation Oncology Learning Outcomes and the Eligibility and Readiness to Sit Phase 2 Examination Policy
To be eligible to apply for the Phase 2 Examination from 2023, trainees must be in Phase 2 of training, be a financial, radiation oncology, student member of the RANZCR, be in an accredited radiation oncology training position and have completed:
See our simple RO Examination Eligibility Checklist.
For further information, please refer to the Eligibility and Readiness to Sit Phase 2 Examination Policy.
These exams are delivery electronically. The three written papers comprised of short answer/short essay questions are aligned to the Radiation Oncology Learning Outcomes.
Total marks: 180
Duration: 3 Hours
Comprised of:
The examination includes planning viva and clinical cases:
The planning viva is designed to assess the candidate’s knowledge of treatment planning equipment. It also assesses their ability to evaluate treatment planning information and to justify the reasons for selecting the most appropriate treatment plan for an individual case.
The clinical cases with clinical prompt images are designed to assess the candidate’s ability to:
They will require the candidate to demonstrate knowledge and skills in relation to:
The Pathology written examination is delivered electronically.
Total marks: 120
Duration: 2 Hours
The RANZCR Radiation Oncology Phase 2 Examinations are delivered via a digital platform. It is essential that candidates practise on the demonstration site before attempting the examination.
Demonstration site: https://demo.ranzcr.practique.net/
The online practice examination replicates the examination platform with use of tools and question navigation and works best on the Google Chrome browser.
The Question Type Demonstration is not intended to be a study tool, but instead a method for candidates to familiarise themselves with the examination delivery platform.
During the actual RANZCR examinations, a countdown timer is provided on the platform to help candidates manage their time. However, this feature has been disabled for the demonstration. Also disabled is the banner indicating reading time.
Demonstration Digital Examination
Login ID: 11007
Password: 11007
The demonstration digital examination site requires PINs to access the different examinations available:
Radiation Oncology Phase 2 Examination Demo PIN: 430694
To complete the examination, candidates must pass both subject areas.
Candidates must take both Radiation Oncology and Pathology on their first attempt of the examination.Once a subject is passed, candidates don't need to retake it and only need to pass the remaining subject within their remaining attempts.Candidates can attempt the Phase 2 Examination up to three times, regardless of whether they take one or both subjects.
Examples of the types of questions being asked in the new Phase 2 written Examination from July 2024.
Sample Questions - July-2024
Frequently asked questions in relation to recent changes to the examinations and the digital platform.
Frequently Asked Questions (FAQs)
Please note, the Phase 2 Examination Course is not a mandatory training requirement.
The Phase 2 Examination Course is conducted by presenters and facilitators including College Phase 2 examiners.
The aims of the Phase 2 Examination Course are to provide:
2022- Series 2
2022 – Series 1
2021
2020 – Series 2
2020 – Series 1
2019 – Series 2
2019 – Series 1
2018 – Series 2
2018 – Series 1
2017 – Series 2
2017 – Series 1
2016 – Series 2
2016 – Series 1
2015 – Series 2
2015 – Series 1
2014 – Series 2
2014 – Series 1
2013 – Series 2
2013 – Series 1
2012
2011
2010
1999 to 2009 (Radiation Therapy)
1999 to 2009 (Clinical Oncology)
1999 to 2009 (Tumour Pathology)